raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne Wojcicki has said she intends to take the company private and is not ...

The Colorado Bureau of Investigation is gearing up for an expensive assessment of its forensics labs after former forensic ...

The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.

The Prostate Health Education Network launched a new online portal focused on precision medicine care for prostate cancer ...

o. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...

There is no cure, and limited treatment options are currently available. The International Alliance of ALS/MND Associations ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

It happened again.” My friend’s voice woke me up quickly. We lived in Glover Park and there had been another sexual assault ...

Natera (NTRA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Daniel Brennan ...

Natera Inc. ( (NTRA) ) has released its Q3 earnings. Here is a breakdown of the information Natera Inc. presented to its investors. Natera Inc.